Autologous dendritic cell vaccine (Petrov Research Institute of Oncology)

N/A

Report date: 2022/01/14 13:23:58

Base Information

Drug NameAutologous dendritic cell vaccine (Petrov Research Institute of Oncology)

Drug Alias NameN/A

ClassificationVaccines > Development/production technology > Dendritic cell vaccineCell and gene therapy > Cell therapy > Immune system cell therapy > Dendritic cell therapy > Dendritic cell vaccine

Mechanisms of ActionImmunostimulants

TargetsNot applicable

Therapy Area/IndicationsSarcoma

Global Approved IndicationsN/A

Approved Indications in ChinaN/A

Original Approved Country/TerritoryN/A

Original Approved DateN/A

Country/TerritoryN/A

CombinationsNo

Global Highest StatusPhase 2 Clinical

Highest Status in ChinaN/A

Originator CompaniesN.N. Petrov Institute Of Oncology

China Registration ClassN/A

Develop Information

Active CompaniesN.N. Petrov Institute Of Oncology

Inactive CompaniesN/A

Active IndicationsSarcoma

Inactive IndicationsN/A

Other Information

ATC CodeN/A